Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Conference Sponsor
7
2020 - 07 - 28
点击次数:
Quanterix is a company that is revolutionizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive digital detection solution, Simoa®, has the potential to transform the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease.
8
2020 - 07 - 24
点击次数:
Accurant Biotech is an outsourcing organization (CRO) focusing on immune-based and cell-based method development, method validation and sample analysis in support of clinical and preclinical trials for biological drug development. We provide one-stop service of biological analysis for global pharma and biotech companies. Our services include preparation of large molecule bioanalysis reagent, development and validation of bioanalytical methodology and sample analysis in compliance with GLP regulations. The founder team is composed of industry experts, some of them are oversea researchers with years of experience in well-known pharmaceutical companies, large molecule biologics bioanalysis expert, or long-standing committee members of several relevant associations in China and US. They participated in the writing of influential guidance white papers in the bioanalysis industry in US and ' Guidelines for biological sample analysis method verification' in Chinese pharmacopoeia of 2015. Accurant Biotech Ningbo site was established in Ningbo High-Tech zone in October 2017 with a registered capital of 10 million RMB. Through the elite talent program, the company was endorsed by the government of Ningbo with incubator fund and laboratory facilities in 2017. In 2018, Accurant was awarded the top 10 “Most Investable Startup” in Ningbo. Accurant Biotech has operations in 3 different cities in China and US. The global operation setup enables Accurant Biotech to provide streamline services for multi-site clinical trials to support biologics drug development.
9
2020 - 07 - 24
点击次数:
Viva Biotech’s mission is to become a cradle for innovative biotechnology companies around the world. Viva Biotech has developed a scalable business model combining the conventional cash-for-service (CFS) model and its unique equity-for-service (EFS) model. Under the CFS model, the Group provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development, covering the full spectrum of the customers’ needs for early stage drug discovery, including target protein structure research, bioassay, hit screening, lead optimization and drug candidate determination. Viva Biotech also provides drug discovery and incubation services to biotechnology start-up companies with high potential under its EFS model.